CMD:NYE-Cantel Medical Corp (USD)

COMMON STOCK | Medical Instruments & Supplies | NYE

Last Closing Price

USD 83.76

Change

+0.38 (+0.46)%

Market Cap

USD 3.52B

Volume

0.34M

Average Target Price

USD 85.00 (+1.48%)
Average Analyst Rating

Verdict

Fundamental Analysis

Verdict

About

Cantel Medical Corp. provides infection prevention and control products and services for the healthcare market. The company's Medical segment offers automated endoscope reprocessing systems; disinfectants and sterilants; detergents; leak testing and manual cleaning products; storage cabinets and transport systems; manual cleaning products; endoscope process tracking products; other consumables, accessories, and supplies for use in disinfect rigid endoscopes, flexible endoscopes, and other instrumentation; and technical maintenance services. Its Life Sciences segment provides dialysis water purification and bicarbonate mixing systems; hollow fiber filters, and other filtration and separation products; liquid disinfectants and cold sterilization products; dry fog products; room temperature sterilization equipment and services; and clean-room certification and decontamination services for the dialysis and other healthcare, research laboratories, food and beverage, and commercial industrial customers, as well as microbiological testing services. The company's Dental segment offers hand and powered dental instruments, instrument reprocessing and sterility assurance products, towels, bibs, tray liners, sponges, nitrous oxide/oxygen sedation equipment and related single-use disposable nasal masks, face masks, and shields. It also provides hand sanitizers, germicidal wipes, disinfectants, surface disinfectants, waterline treatment products, saliva ejectors, evacuator tips, plastic cups, prophy angles, and prophy paste. The company's Dialysis segment provides hemodialysis concentrates and other ancillary supplies; medical device reprocessing systems; and sterilants and disinfectants. The company sells its products through its direct distribution network in the United States; and directly or under various third-party distribution agreements internationally. Cantel Medical Corp. was founded in 1963 and is headquartered in Little Falls, New Jersey.

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2021-04-09 )

Largest Industry Peers for Medical Instruments & Supplies

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
BDX Becton, Dickinson and Company

+5.06 (+2.08%)

USD70.57B 46.21 19.10
BAX Baxter International Inc

+0.92 (+1.10%)

USD42.48B 39.44 20.16
ALC Alcon Inc

+0.73 (+1.00%)

USD35.53B N/A 34.36
RMD ResMed Inc

+1.92 (+0.97%)

USD28.70B 41.18 27.57
WST West Pharmaceutical Services, ..

+4.64 (+1.59%)

USD21.56B 63.87 40.92
TFX Teleflex Incorporated

+6.94 (+1.65%)

USD19.64B 59.26 33.74
COO The Cooper Companies, Inc

+5.03 (+1.32%)

USD18.73B 8.40 33.10
STE STERIS plc

+0.99 (+0.50%)

USD16.91B 39.40 23.63
VAR Varian Medical Systems, Inc

-0.01 (-0.01%)

USD16.28B 58.45 32.89
HRC Hill-Rom Holdings, Inc

+1.56 (+1.40%)

USD7.39B 30.84 16.06

ETFs Containing CMD

Symbol Name Weight Mer Price(Change) Market Cap
EVX VanEck Vectors Environmen.. 0.00 % 0.55 %

+1.62 (+1.20%)

USD0.04B

Market Performance

  Market Performance vs.
Industry/Classification (Medical Instruments & Supplies)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 6.21% 52% F 48% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 6.21% 52% F 46% F
Trailing 12 Months  
Capital Gain 118.69% 75% C 85% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 118.69% 75% C 84% B
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain -3.91% 5% F 22% F
Dividend Return 0.16% 20% F 3% F
Total Return -3.75% 5% F 17% F
Risk Return Profile  
Volatility (Standard Deviation) 36.02% 50% F 22% F
Risk Adjusted Return -10.41% 5% F 19% F
Market Capitalization 3.52B 35% F 69% D+
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 87%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Medical Instruments & Supplies)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 76.57 11% F 10% F
Price/Book Ratio 4.44 70% C- 24% F
Price / Cash Flow Ratio 25.75 45% F 14% F
EV/EBITDA 22.47 69% D+ 29% F
Management Effectiveness  
Return on Equity 6.19% 38% F 53% F
Return on Invested Capital 4.11% 55% F 49% F
Return on Assets 4.24% 57% F 75% C
Debt to Equity Ratio 144.14% 6% F 25% F
Technical Ratios  
Short Ratio 3.55 48% F 22% F
Short Percent 6.10% 21% F 41% F
Beta 1.54 25% F 24% F
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.

Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Poor return on equity

The company management has delivered below median return on equity in the most recent 4 quarters compared to its peers.

Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector